TY - JOUR
T1 - A comprehensive review of coronavirus disease 2019
T2 - Epidemiology, transmission, risk factors, and international responses
AU - Li, Han
AU - Burm, Seung Won
AU - Hong, Sung Hwi
AU - Ghayda, Ramy Abou
AU - Kronbichler, Andreas
AU - Smith, Lee
AU - Koyanagi, Ai
AU - Jacob, Louis
AU - Lee, Keum Hwa
AU - Shin, Jae Il
N1 - Publisher Copyright:
© Yonsei University College of Medicine 2021.
PY - 2021/1
Y1 - 2021/1
N2 - Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide pandemic. The first reports of patients with COVID-19 were provided to World Health Organization on December 21, 2019 and were presumably associated with seafood markets in Wuhan, China. As of October 25, 2020, more than 42 million cases have been confirmed worldwide, with more than 1.1 million deaths. Asymptomatic transmission contributes significantly to transmission, and clinical features are non-specific to the disease. Thus, the diagnosis of COVID-19 requires specific viral RNA testing. The disease demonstrates extensive human-to-human transmissibility and has infected healthcare workers at high rates. Clinical awareness of the epidemiology and the risk factors for nosocomial transmission of COVID-19 is essential to preventing infection. Moreover, effective control measures should be further identified by comprehensive evaluation of hospital and community responses. In this review, we provide a comprehensive update on the epidemiology, presentation, transmission, risk factors, and public health measures associated with COVID-19. We also review past insights from previous coronavirus epidemics [i.e., severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)] to suggest measures to reduce transmission.
AB - Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide pandemic. The first reports of patients with COVID-19 were provided to World Health Organization on December 21, 2019 and were presumably associated with seafood markets in Wuhan, China. As of October 25, 2020, more than 42 million cases have been confirmed worldwide, with more than 1.1 million deaths. Asymptomatic transmission contributes significantly to transmission, and clinical features are non-specific to the disease. Thus, the diagnosis of COVID-19 requires specific viral RNA testing. The disease demonstrates extensive human-to-human transmissibility and has infected healthcare workers at high rates. Clinical awareness of the epidemiology and the risk factors for nosocomial transmission of COVID-19 is essential to preventing infection. Moreover, effective control measures should be further identified by comprehensive evaluation of hospital and community responses. In this review, we provide a comprehensive update on the epidemiology, presentation, transmission, risk factors, and public health measures associated with COVID-19. We also review past insights from previous coronavirus epidemics [i.e., severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)] to suggest measures to reduce transmission.
UR - http://www.scopus.com/inward/record.url?scp=85099231755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099231755&partnerID=8YFLogxK
U2 - 10.3349/ymj.2021.62.1.1
DO - 10.3349/ymj.2021.62.1.1
M3 - Review article
C2 - 33381929
AN - SCOPUS:85099231755
SN - 0513-5796
VL - 62
SP - 1
EP - 11
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
IS - 1
ER -